Semaglutide Drugs
- All
- News
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Nature's Ozempic: What And How You Eat Affects Your Weight Loss Journey
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications.
-
Ozempic Face? Woman Says It Made Her Look 10 Years Younger
The debate surrounding Ozempic and similar weight loss drugs highlights the benefits and drawbacks of medical weight loss, with some users experiencing positive effects on their appearance and others facing concerns about side effects.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Weight-Loss Injections May Increase Blindness Risk, Study Warns
A recent study in JAMA Ophthalmology links semaglutide medications, used for weight loss and diabetes, to an increased risk of NAION, a rare eye condition causing sudden vision loss.
-
Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.
-
Research Reveals Popular Obesity Treatment That Could Help Fight Cancer
Despite whether or not patients experience weight loss, a well-known anti-obesity medication has been proven to reinstate the functionality of immune cells that fight cancer.
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Nature's Ozempic: What And How You Eat Affects Your Weight Loss Journey
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications.
-
Ozempic Face? Woman Says It Made Her Look 10 Years Younger
The debate surrounding Ozempic and similar weight loss drugs highlights the benefits and drawbacks of medical weight loss, with some users experiencing positive effects on their appearance and others facing concerns about side effects.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Weight-Loss Injections May Increase Blindness Risk, Study Warns
A recent study in JAMA Ophthalmology links semaglutide medications, used for weight loss and diabetes, to an increased risk of NAION, a rare eye condition causing sudden vision loss.
-
Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.
-
Research Reveals Popular Obesity Treatment That Could Help Fight Cancer
Despite whether or not patients experience weight loss, a well-known anti-obesity medication has been proven to reinstate the functionality of immune cells that fight cancer.
